At a glance
- Originator Servier
- Class Antihyperglycaemics; Antiplatelets
- Mechanism of Action Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic nephropathies; Thrombosis
Most Recent Events
- 22 Sep 1998 No-Development-Reported for Thrombosis in France (Unknown route)
- 03 Aug 1998 No-Development-Reported for Diabetic nephropathies in France (Unknown route)
- 14 May 1996 Preclinical development for Diabetic nephropathies in France (Unknown route)